+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anti Tumour Necrosis Factor"

Psoriasis Treatment Market Analysis & Forecast 2024-2034: Market By Drug Class; By Type; By Route Of Administration; and By Region - Product Thumbnail Image

Psoriasis Treatment Market Analysis & Forecast 2024-2034: Market By Drug Class; By Type; By Route Of Administration; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Psoriatic Arthritis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 to 2032 - Product Thumbnail Image

Psoriatic Arthritis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 to 2032

  • Report
  • May 2024
  • 170 Pages
  • Global
From
Tumor Necrosis Factor (TNF) Inhibitors MarkeSize, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029 - Product Thumbnail Image

Tumor Necrosis Factor (TNF) Inhibitors MarkeSize, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • Report
  • September 2021
  • 111 Pages
  • Global
From
Psoriatic Arthritis Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027 - Product Thumbnail Image

Psoriatic Arthritis Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027

  • Report
  • October 2022
  • 270 Pages
  • Global
From
Crohn's Disease Therapeutics Market Forecast - Epidemiology & Pipeline Analysis - Product Thumbnail Image

Crohn's Disease Therapeutics Market Forecast - Epidemiology & Pipeline Analysis

  • Report
  • September 2022
  • 232 Pages
  • Global
From
Ulcerative Colitis Market Forecast - Epidemiology & Pipeline Analysis 2022-2027 - Product Thumbnail Image

Ulcerative Colitis Market Forecast - Epidemiology & Pipeline Analysis 2022-2027

  • Report
  • August 2022
  • 222 Pages
  • Global
From
Graft Versus Host Disease (GvHD) Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027 - Product Thumbnail Image

Graft Versus Host Disease (GvHD) Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027

  • Report
  • May 2022
  • 190 Pages
  • Global
From
Japan Rheumatoid Arthritis Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

Japan Rheumatoid Arthritis Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • September 2024
  • 82 Pages
  • Japan
From
Adalimumab Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Adalimumab Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • June 2025
  • 185 Pages
  • Global
From
Japan Psoriasis Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

Japan Psoriasis Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • September 2024
  • 82 Pages
  • Japan
From
Japan Inflammatory Bowel Disease (IBD) Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F - Product Thumbnail Image

Japan Inflammatory Bowel Disease (IBD) Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F

  • Report
  • August 2024
  • 80 Pages
  • Japan
From
Ulcerative Colitis Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Thumbnail Image

Ulcerative Colitis Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • October 2023
  • 190 Pages
  • Global
From
Axial Spondyloarthritis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 - Product Thumbnail Image

Axial Spondyloarthritis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027

  • Report
  • June 2023
  • 112 Pages
  • Global
From
Ulcerative Colitis - Pipeline Insight, 2025 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
RIPK1 Inhibitor - Pipeline Insights, 2025 - Product Thumbnail Image

RIPK1 Inhibitor - Pipeline Insights, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Mastocytosis - Pipeline Insight, 2025 - Product Thumbnail Image

Mastocytosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD30 Therapies - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD30 Therapies - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cryoprin-Associated Periodic Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Cryoprin-Associated Periodic Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
US HUMIRA Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

US HUMIRA Market Size, Forecast, and Market Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • United States
Axial Spondyloarthritis (axSpA) Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Axial Spondyloarthritis (axSpA) Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Loading Indicator

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications. The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more